Knights of Columbus Asset Advisors’s Cardlytics CDLX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,293	Closed	-$1.42M	–	307
2021 Q1	$1.42M	Sell	1,293 -18	-1%	-$23.8K	0.14%	224
2020 Q4	$1.87M	Sell	1,311 -840	-39%	-$896K	0.2%	180
2020 Q3	$1.52M	Sell	2,151 -327	-13%	-$238K	0.19%	175
2020 Q2	$1.73M	Sell	2,478 -18	-0.7%	-$10.4K	0.21%	146
2020 Q1	$872K	Buy	+2,496	New	+$1.77M	0.11%	264

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Knights of Columbus Asset Advisors's CDLX Position: Q2 2021 in Review

Knights of Columbus Asset Advisors sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 1,293 shares — an estimated $1.42M sold.

Knights of Columbus Asset Advisors first reported a position in CDLX in Q1 2020 and held it in 5 quarters. The position peaked at $1.87M in Q4 2020. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

Knights of Columbus Asset Advisors reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
Knights of Columbus Asset Advisors sold 1,293 Cardlytics shares in Q2 2021, an estimated $1.42M.
Knights of Columbus Asset Advisors first reported a position in Cardlytics in Q1 2020 and held it in 5 quarters.
Knights of Columbus Asset Advisors's Cardlytics position peaked at $1.87M in Q4 2020.
189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.